Outset Medical, Inc. OM
Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2020 · data as of November 13, 2026
Outset Medical, Inc. (OM) is a healthcare company listed in the US with a market value of about $70M. In the twelve months to September 30, 2026 it had revenue of $122M and net income of -$71M, a net margin of -58.3%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 19% a year, a 5-year average ROIC of -35%.
About Outset Medical
Outset Medical is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2020. Revenue went from $2M in 2018 to $119M in 2025, growth of about 79.3% a year. It was profitable in 0 of the last 8 years in our data. Its share count rose by 374% over three years (dilution for shareholders). It spends 18% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $122M | $119M | $114M | $130M | $115M | $103M | $50M | $15M | $2M |
| Net income | -$71M | -$82M | -$128M | -$173M | -$163M | -$132M | -$121M | -$68M | -$50M |
| Free cash flow | -$43M | -$47M | -$117M | -$135M | -$154M | -$133M | -$108M | -$74M | -$48M |
| EPS (diluted) | $-3.78 | $-5.37 | $-36.96 | $-52.28 | $-50.71 | $-43.36 | $-72.77 | $-1494.09 | $-1511.65 |
| Net margin | -58.3% | -68.3% | -112.6% | -132.5% | -141.2% | -128.6% | -243.3% | -453.0% | -2480.3% |
| ROIC | — | -23.1% | -39.2% | -51.8% | -35.9% | -24.9% | -31.8% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Outset Medical pay a dividend?
Not currently.
Is Outset Medical a good stock to buy?
We do not give buy or sell advice. Outset Medical scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.